Profil
Peter L.
Saltonstall is currently a Director at Trio Health Advisory Group, Inc. and a Director at Medical Device Innovation Consortium.
He was previously the President, Chief Executive Officer & Director at The National Organization for Rare Disorders, Inc.
Aktive Positionen von Peter L. Saltonstall
| Unternehmen | Position | Beginn |
|---|---|---|
Medical Device Innovation Consortium
Medical Device Innovation Consortium Miscellaneous Commercial ServicesCommercial Services Operates as trade association for processing, improving and advancing medical technologies | Direktor/Vorstandsmitglied | 01.02.2016 |
Trio Health Advisory Group, Inc.
Trio Health Advisory Group, Inc. Packaged SoftwareTechnology Services Develops proprietary technology platform | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Peter L. Saltonstall
| Unternehmen | Position | Ende |
|---|---|---|
The National Organization for Rare Disorders, Inc.
The National Organization for Rare Disorders, Inc. Services to the Health IndustryHealth Services Provides medical funding and healthcare services | Vorstandsvorsitzender | 01.05.2024 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Trio Health Advisory Group, Inc.
Trio Health Advisory Group, Inc. Packaged SoftwareTechnology Services Develops proprietary technology platform | Technology Services |
The National Organization for Rare Disorders, Inc.
The National Organization for Rare Disorders, Inc. Services to the Health IndustryHealth Services Provides medical funding and healthcare services | Health Services |
Medical Device Innovation Consortium
Medical Device Innovation Consortium Miscellaneous Commercial ServicesCommercial Services Operates as trade association for processing, improving and advancing medical technologies | Commercial Services |
















